Lates News

Merck: Reaches agreement with the US Department of Commerce to delay tariffs for three years. Merck aims to expand drug access channels and lower drug costs for American people, with Januvia, Janumet, and Janumet XR being supplied to eligible US patients at a cash price approximately 30% off the current list price. The company also pledges to invest over $70 billion in the United States.